Stocks
Iovance Biotherapeutics (IOVA) Operating Income US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| Operating Income, bln rub | -342.7 | -398.9 | -460.6 | -395.3 | -403.4 | -363.2 | |||
| Changes by years, y/y, % | +31% | +16% | +15% | -14% | +2% | +9.0% | |||
Iovance Biotherapeutics. Operating Income, bln rub
Iovance Biotherapeutics. Operating Income, changes, %
Iovance Biotherapeutics. Operating Income, sum by quarters, bln rub
Iovance Biotherapeutics (IOVA) Operating Income US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| Operating Income, bln rub | -121.2 | -113.8 | -94.9 | -73.5 | -81.0 | -363.2 | ||
| Changes by years, y/y, % | +3% | +12% | +7% | -15% | -33% | |||
| Changes by quarters, q/q, % | +40% | -6% | -17% | -23% | +10% | |||
